Loading…
Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men
Cigarette smoking is a risk factor for cardiovascular disease. The present study addressed the effect of tobacco use on the formation of two eicosanoids, thromboxane A2 and prostacyclin, which have been implicated in both acute and chronic cardiovascular disorders. In 577 randomly sampled 18-19-year...
Saved in:
Published in: | Circulation (New York, N.Y.) N.Y.), 1991-05, Vol.83 (5), p.1698-1704 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c473t-3d5379f6631c9888269e4afaba5bfde10557e875ec19cdf77e1e3556b18149de3 |
---|---|
cites | |
container_end_page | 1704 |
container_issue | 5 |
container_start_page | 1698 |
container_title | Circulation (New York, N.Y.) |
container_volume | 83 |
creator | WENNMALM, A BENTHIN, G GRANSTROM, E. F PERSSON, L PETERSSON, A.-S WINELL, S |
description | Cigarette smoking is a risk factor for cardiovascular disease. The present study addressed the effect of tobacco use on the formation of two eicosanoids, thromboxane A2 and prostacyclin, which have been implicated in both acute and chronic cardiovascular disorders.
In 577 randomly sampled 18-19-year-old men, the urinary excretion of the 2,3-dinor metabolites of thromboxane A2 and prostacyclin (Tx-M and PGI-M, respectively) was analyzed and related to the subjects' self-reported use of tobacco. Sixty-five percent of the subjects used no tobacco, 7.5% were cigarette smokers, 22% used wet (oral) snuff, and the rest reported a mixed use of tobacco. The urinary excretion of Tx-M was higher (p less than 0.001) in cigarette smokers than in those not using tobacco (180 versus 128 pg/mg creatinine) and was correlated (r = 0.35, p less than 0.05) with the daily cigarette consumption. Snuff users had no increase in their urinary excretion of Tx-M, despite urinary cotinine levels comparable to those in the cigarette smokers (1,210 and 1,560 ng/ml, respectively). The excretion of PGI-M did not differ between non-tobacco users, cigarette smokers, and snuff users.
We conclude that cigarette smoking, but not the use of snuff, facilitates the formation of thromboxane A2. We propose that such an increased formation reflects platelet activation in the absence of vascular injury and that it may be of significance for the subsequent development of cardiovascular disease. |
doi_str_mv | 10.1161/01.cir.83.5.1698 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80532452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80532452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-3d5379f6631c9888269e4afaba5bfde10557e875ec19cdf77e1e3556b18149de3</originalsourceid><addsrcrecordid>eNpFUE1r3TAQFKUhfUl776WgS3uzow-vJR3DI20DgUJIz0KW162LLaWSTPP-fZTkkcLCsjuzw-wQ8pGzlvOeXzDe-jm1WrbQ8t7oN2THQXRNB9K8JTvGmGmUFOIdOcv5Tx17qeCUnAomasGOhFtcXJljoAOWf4iBljg47yPdMlIXRrqlObh0oPjgEz4z40TL7xTXIT64gPRSPPPuU8zF-YNf5kBXLG6Iy1ww0zoe4hZ-1WV4T04mt2T8cOzn5OfXq7v99-bmx7fr_eVN4zslSyNHkMpMfS-5N1pr0Rvs3OQGB8M0ImcACrUC9Nz4cVIKOUqAfuCad2ZEeU6-vOhWV383zMWuc_a4LNVw3LLVDKToQFQieyH6aj8nnOx9mtf6r-XMPkVsGbf761urpQX7FHE9-XTU3oYVx9eDY6YV_3zEXfZumZILfs7_dY0ywEDLR5vxhd4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80532452</pqid></control><display><type>article</type><title>Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men</title><source>Open Access Journals</source><creator>WENNMALM, A ; BENTHIN, G ; GRANSTROM, E. F ; PERSSON, L ; PETERSSON, A.-S ; WINELL, S</creator><creatorcontrib>WENNMALM, A ; BENTHIN, G ; GRANSTROM, E. F ; PERSSON, L ; PETERSSON, A.-S ; WINELL, S</creatorcontrib><description>Cigarette smoking is a risk factor for cardiovascular disease. The present study addressed the effect of tobacco use on the formation of two eicosanoids, thromboxane A2 and prostacyclin, which have been implicated in both acute and chronic cardiovascular disorders.
In 577 randomly sampled 18-19-year-old men, the urinary excretion of the 2,3-dinor metabolites of thromboxane A2 and prostacyclin (Tx-M and PGI-M, respectively) was analyzed and related to the subjects' self-reported use of tobacco. Sixty-five percent of the subjects used no tobacco, 7.5% were cigarette smokers, 22% used wet (oral) snuff, and the rest reported a mixed use of tobacco. The urinary excretion of Tx-M was higher (p less than 0.001) in cigarette smokers than in those not using tobacco (180 versus 128 pg/mg creatinine) and was correlated (r = 0.35, p less than 0.05) with the daily cigarette consumption. Snuff users had no increase in their urinary excretion of Tx-M, despite urinary cotinine levels comparable to those in the cigarette smokers (1,210 and 1,560 ng/ml, respectively). The excretion of PGI-M did not differ between non-tobacco users, cigarette smokers, and snuff users.
We conclude that cigarette smoking, but not the use of snuff, facilitates the formation of thromboxane A2. We propose that such an increased formation reflects platelet activation in the absence of vascular injury and that it may be of significance for the subsequent development of cardiovascular disease.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.cir.83.5.1698</identifier><identifier>PMID: 2022025</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>6-Ketoprostaglandin F1 alpha - analogs & derivatives ; 6-Ketoprostaglandin F1 alpha - urine ; Adolescent ; Adult ; Biological and medical sciences ; Epoprostenol - metabolism ; Humans ; Male ; Medical sciences ; Osmolar Concentration ; Smoking ; Thromboxane A2 - metabolism ; Thromboxane B2 - analogs & derivatives ; Thromboxane B2 - urine ; Tobacco, tobacco smoking ; Toxicology</subject><ispartof>Circulation (New York, N.Y.), 1991-05, Vol.83 (5), p.1698-1704</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-3d5379f6631c9888269e4afaba5bfde10557e875ec19cdf77e1e3556b18149de3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>310,311,315,786,790,795,796,23958,23959,25170,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19795058$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2022025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WENNMALM, A</creatorcontrib><creatorcontrib>BENTHIN, G</creatorcontrib><creatorcontrib>GRANSTROM, E. F</creatorcontrib><creatorcontrib>PERSSON, L</creatorcontrib><creatorcontrib>PETERSSON, A.-S</creatorcontrib><creatorcontrib>WINELL, S</creatorcontrib><title>Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Cigarette smoking is a risk factor for cardiovascular disease. The present study addressed the effect of tobacco use on the formation of two eicosanoids, thromboxane A2 and prostacyclin, which have been implicated in both acute and chronic cardiovascular disorders.
In 577 randomly sampled 18-19-year-old men, the urinary excretion of the 2,3-dinor metabolites of thromboxane A2 and prostacyclin (Tx-M and PGI-M, respectively) was analyzed and related to the subjects' self-reported use of tobacco. Sixty-five percent of the subjects used no tobacco, 7.5% were cigarette smokers, 22% used wet (oral) snuff, and the rest reported a mixed use of tobacco. The urinary excretion of Tx-M was higher (p less than 0.001) in cigarette smokers than in those not using tobacco (180 versus 128 pg/mg creatinine) and was correlated (r = 0.35, p less than 0.05) with the daily cigarette consumption. Snuff users had no increase in their urinary excretion of Tx-M, despite urinary cotinine levels comparable to those in the cigarette smokers (1,210 and 1,560 ng/ml, respectively). The excretion of PGI-M did not differ between non-tobacco users, cigarette smokers, and snuff users.
We conclude that cigarette smoking, but not the use of snuff, facilitates the formation of thromboxane A2. We propose that such an increased formation reflects platelet activation in the absence of vascular injury and that it may be of significance for the subsequent development of cardiovascular disease.</description><subject>6-Ketoprostaglandin F1 alpha - analogs & derivatives</subject><subject>6-Ketoprostaglandin F1 alpha - urine</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Epoprostenol - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Osmolar Concentration</subject><subject>Smoking</subject><subject>Thromboxane A2 - metabolism</subject><subject>Thromboxane B2 - analogs & derivatives</subject><subject>Thromboxane B2 - urine</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpFUE1r3TAQFKUhfUl776WgS3uzow-vJR3DI20DgUJIz0KW162LLaWSTPP-fZTkkcLCsjuzw-wQ8pGzlvOeXzDe-jm1WrbQ8t7oN2THQXRNB9K8JTvGmGmUFOIdOcv5Tx17qeCUnAomasGOhFtcXJljoAOWf4iBljg47yPdMlIXRrqlObh0oPjgEz4z40TL7xTXIT64gPRSPPPuU8zF-YNf5kBXLG6Iy1ww0zoe4hZ-1WV4T04mt2T8cOzn5OfXq7v99-bmx7fr_eVN4zslSyNHkMpMfS-5N1pr0Rvs3OQGB8M0ImcACrUC9Nz4cVIKOUqAfuCad2ZEeU6-vOhWV383zMWuc_a4LNVw3LLVDKToQFQieyH6aj8nnOx9mtf6r-XMPkVsGbf761urpQX7FHE9-XTU3oYVx9eDY6YV_3zEXfZumZILfs7_dY0ywEDLR5vxhd4</recordid><startdate>19910501</startdate><enddate>19910501</enddate><creator>WENNMALM, A</creator><creator>BENTHIN, G</creator><creator>GRANSTROM, E. F</creator><creator>PERSSON, L</creator><creator>PETERSSON, A.-S</creator><creator>WINELL, S</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910501</creationdate><title>Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men</title><author>WENNMALM, A ; BENTHIN, G ; GRANSTROM, E. F ; PERSSON, L ; PETERSSON, A.-S ; WINELL, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-3d5379f6631c9888269e4afaba5bfde10557e875ec19cdf77e1e3556b18149de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>6-Ketoprostaglandin F1 alpha - analogs & derivatives</topic><topic>6-Ketoprostaglandin F1 alpha - urine</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Epoprostenol - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Osmolar Concentration</topic><topic>Smoking</topic><topic>Thromboxane A2 - metabolism</topic><topic>Thromboxane B2 - analogs & derivatives</topic><topic>Thromboxane B2 - urine</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WENNMALM, A</creatorcontrib><creatorcontrib>BENTHIN, G</creatorcontrib><creatorcontrib>GRANSTROM, E. F</creatorcontrib><creatorcontrib>PERSSON, L</creatorcontrib><creatorcontrib>PETERSSON, A.-S</creatorcontrib><creatorcontrib>WINELL, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WENNMALM, A</au><au>BENTHIN, G</au><au>GRANSTROM, E. F</au><au>PERSSON, L</au><au>PETERSSON, A.-S</au><au>WINELL, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1991-05-01</date><risdate>1991</risdate><volume>83</volume><issue>5</issue><spage>1698</spage><epage>1704</epage><pages>1698-1704</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Cigarette smoking is a risk factor for cardiovascular disease. The present study addressed the effect of tobacco use on the formation of two eicosanoids, thromboxane A2 and prostacyclin, which have been implicated in both acute and chronic cardiovascular disorders.
In 577 randomly sampled 18-19-year-old men, the urinary excretion of the 2,3-dinor metabolites of thromboxane A2 and prostacyclin (Tx-M and PGI-M, respectively) was analyzed and related to the subjects' self-reported use of tobacco. Sixty-five percent of the subjects used no tobacco, 7.5% were cigarette smokers, 22% used wet (oral) snuff, and the rest reported a mixed use of tobacco. The urinary excretion of Tx-M was higher (p less than 0.001) in cigarette smokers than in those not using tobacco (180 versus 128 pg/mg creatinine) and was correlated (r = 0.35, p less than 0.05) with the daily cigarette consumption. Snuff users had no increase in their urinary excretion of Tx-M, despite urinary cotinine levels comparable to those in the cigarette smokers (1,210 and 1,560 ng/ml, respectively). The excretion of PGI-M did not differ between non-tobacco users, cigarette smokers, and snuff users.
We conclude that cigarette smoking, but not the use of snuff, facilitates the formation of thromboxane A2. We propose that such an increased formation reflects platelet activation in the absence of vascular injury and that it may be of significance for the subsequent development of cardiovascular disease.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>2022025</pmid><doi>10.1161/01.cir.83.5.1698</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7322 |
ispartof | Circulation (New York, N.Y.), 1991-05, Vol.83 (5), p.1698-1704 |
issn | 0009-7322 1524-4539 |
language | eng |
recordid | cdi_proquest_miscellaneous_80532452 |
source | Open Access Journals |
subjects | 6-Ketoprostaglandin F1 alpha - analogs & derivatives 6-Ketoprostaglandin F1 alpha - urine Adolescent Adult Biological and medical sciences Epoprostenol - metabolism Humans Male Medical sciences Osmolar Concentration Smoking Thromboxane A2 - metabolism Thromboxane B2 - analogs & derivatives Thromboxane B2 - urine Tobacco, tobacco smoking Toxicology |
title | Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T02%3A00%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relation%20between%20tobacco%20use%20and%20urinary%20excretion%20of%20thromboxane%20A2%20and%20prostacyclin%20metabolites%20in%20young%20men&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=WENNMALM,%20A&rft.date=1991-05-01&rft.volume=83&rft.issue=5&rft.spage=1698&rft.epage=1704&rft.pages=1698-1704&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.cir.83.5.1698&rft_dat=%3Cproquest_cross%3E80532452%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-3d5379f6631c9888269e4afaba5bfde10557e875ec19cdf77e1e3556b18149de3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80532452&rft_id=info:pmid/2022025&rfr_iscdi=true |